A disposable blood bag can be defined as a sterile, clear plastic bag used for transfer, storage, collection, and transfusion of blood and its components. It consists of multiple bags interconnected by tubes, clamps, needles, and needle covers. These blood bags are manufactured from bio-compatible PVC materials and additives to preserve blood and its components until further use. The global disposable blood bag market was valued at $279 million in 2016, and is estimated to reach at $580 million by 2023, registering a CAGR of 11.0% from 2017 to 2023. The volume of disposable blood bag market was 275 million units in 2016 and is expected to reach by 556 million units by 2023, registering a CAGR of 10.5%.... Research Beam Model: Research Beam Product ID: 2887276 5370 USD New
Disposable Blood Bag Market by Product (Collection Bag and Transfer Bag) and End User (Hospital Based and Stand-alone) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

Disposable Blood Bag Market by Product (Collection Bag and Transfer Bag) and End User (Hospital Based and Stand-alone) - Global Opportunity Analysis and Industry Forecast, 2017-2023

 
  • Category : Healthcare
  • Published On : January  2018
  • Pages : 185
 
 

A disposable blood bag can be defined as a sterile, clear plastic bag used for transfer, storage, collection, and transfusion of blood and its components. It consists of multiple bags interconnected by tubes, clamps, needles, and needle covers. These blood bags are manufactured from bio-compatible PVC materials and additives to preserve blood and its components until further use. The global disposable blood bag market was valued at $279 million in 2016, and is estimated to reach at $580 million by 2023, registering a CAGR of 11.0% from 2017 to 2023. The volume of disposable blood bag market was 275 million units in 2016 and is expected to reach by 556 million units by 2023, registering a CAGR of 10.5%.

Increase in blood transfusion procedures and high incidence of accidents and trauma cases around the globe drive the market growth. Moreover, rise in prevalence of various blood-related diseases, such as sickle cell anemia, blood cancer, hemophilia, and others, is expected to boost this growth. However, risks related to blood transfusion and low number of blood donations in underdeveloped regions limit this market growth. On the other hand, rise in healthcare infrastructure and presence of lucrative opportunities in emerging countries are expected to provide numerous opportunities for market expansion during the forecast period.

The disposable blood bag market is segmented based on product, end user, and region. Based on product, it is divided into collection bag and transfer bag. The end users studied in this market include into hospital-based and stand-alone end users. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY MARKET BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the global disposable blood bag market and the current trends and future estimations to elucidate the imminent investment pockets.
  • It presents a quantitative analysis of the market from 2016 to 2023 to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the market based on end user assists to understand the trends in the industry.
  • Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

KEY MARKET SEGMENTS

By Product 

  • Collection Bag
  • Transfer Bag

By End User 

  • Hospital Based
  • Stand-alone

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Turkey
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

KEY PLAYERS PROFILED IN THE REPORT

  • Fresenius SE & Co. KGaA
  • Terumo Corporation
  • Grifols, S.A
  • MacoPharma S.A.
  • HLL Lifecare Limited
  • Poly Medicure Limited
  • INNVOL Medical India Limited
  • Span Healthcare Private Limited
  • Haemonetics Corporation
  • Neomedic International